hg_191839.1

Basic information about the TSS

---

TSS ID: hg_191839.1 Species: human Chr: chr22		Start: 31944495 End: 31944524 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000443669.5 ENST00000397492.1 uc062dmb.1 uc062dmc.1 Distance: 0 GeneID: 7533 HGNC/MGI_ID: HGNC:12853 UniProt_ID: A2IDB1 F8WEB6

Gene_name: tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta Gene_symbol: YWHAH Gene_synonyms: Gene_source: HGNC:12853

TATA-Box annotation

---

Distance to TSS:	17
Nearest PromoterID:	NM_003405
Entrez ID:	7533
Nearest Unigene:	Hs.226755
Nearest Refseq:	NM_003405
Nearest Ensembl:	ENSG00000128245
Gene Name:	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta
Gene Alias:	YWHA1
Gene Description:	tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein eta
Gene Type:	protein-coding
CpG%:	0.15
GC%:	0.79602
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@YWHAH p2@YWHAH p3@YWHAH p6@YWHAH p7@YWHAH
Sample		p1@YWHAH	p2@YWHAH	p3@YWHAH	p6@YWHAH	p7@YWHAH
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	52.21	14.42	0.19	0.78	1.56
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	51.59	18.41	0.40	0.40	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	54.40	16.01	0.19	0.77	1.54
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	45.32	13.72	0.00	0.62	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	47.69	12.82	0.45	0.90	0.90
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	42.25	12.60	0.00	0.39	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	40.31	16.78	0.44	0.44	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	36.58	15.50	0.48	0.73	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	42.74	16.46	0.85	0.85	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	38.83	8.11	1.16	0.58	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	32.74	10.11	0.00	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	50.41	7.72	0.41	0.00	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	12.25	12.41	0.48	0.16	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	10.52	12.48	0.60	0.60	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.44	12.29	0.44	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.56	11.57	0.25	0.25	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	8.30	10.92	0.44	0.00	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	7.17	8.86	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	7.46	11.73	0.53	0.53	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.39	10.98	0.30	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	13.77	11.49	0.67	0.13	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	15.54	11.22	1.21	0.35	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	14.35	9.95	1.03	0.65	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	14.80	13.35	0.49	0.49	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.00	10.58	1.03	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	8.86	13.93	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	6.04	8.24	0.55	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	18.15	12.73	0.94	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.47	10.66	0.48	0.48	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.01	12.12	0.18	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.26	10.68	0.84	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	11.14	9.96	0.20	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.55	9.92	0.21	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	14.18	10.56	1.32	0.66	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.64	10.85	0.19	0.37	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.37	11.69	0.19	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.74	8.58	0.41	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.11	9.47	0.40	0.60	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	12.96	6.75	0.81	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	15.60	10.56	0.48	0.96	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	13.88	12.94	0.24	0.47	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.08	10.25	0.29	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	18.77	7.59	0.21	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	18.01	10.14	0.52	0.17	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	16.66	9.64	0.20	0.40	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	19.77	8.14	0.23	0.93	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	18.23	14.39	0.48	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	14.01	10.73	0.60	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	22.26	11.73	0.72	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	16.58	7.48	0.40	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	18.65	8.40	0.41	0.82	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.02	12.23	0.67	1.11	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	111.94	27.98	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.42	14.19	0.35	0.00	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	19.88	15.58	0.33	0.33	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	56.21	26.85	0.00	4.19	6.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	28.01	12.40	0.46	1.84	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	22.04	14.26	1.62	0.65	2.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	18.31	13.49	0.96	0.64	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	23.57	10.06	0.00	0.63	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.79	14.81	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.75	14.02	0.00	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	10.35	0.00	1.59	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.44	9.51	0.00	1.36	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	22.74	13.97	0.97	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	20.23	15.26	0.71	0.71	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	96.98	48.49	0.00	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	86.87	63.18	15.79	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.25	17.06	1.95	0.49	3.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	27.27	20.33	2.48	0.99	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	21.11	13.60	0.47	0.47	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	26.50	16.89	0.33	1.32	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.06	22.58	0.93	0.31	2.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	20.79	20.48	0.61	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	44.66	20.91	0.32	0.32	0.48
Adipocyte - breast, donor2	11327-117E4	42.51	13.96	0.32	1.12	1.28
Adipocyte - omental, donor1	11473-119C6	46.44	27.10	0.25	0.38	0.76
Adipocyte - omental, donor2	11474-119C7	64.28	28.40	0.00	4.48	1.49
Adipocyte - omental, donor3	11475-119C8	31.48	23.11	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	37.00	22.33	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	19.79	7.70	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	16.26	12.65	0.45	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.30	5.73	0.00	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	20.93	18.19	0.39	0.59	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	20.85	10.81	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	22.30	15.61	0.28	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	25.28	29.39	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	30.48	14.64	0.32	0.16	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	21.95	12.59	0.00	0.00	0.97
Adipocyte differentiation, day08, donor3	13026-139E2	23.99	9.06	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	20.03	14.47	1.67	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	40.76	15.39	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	26.87	12.81	1.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	23.89	11.13	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	37.45	14.01	0.91	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	65.19	46.63	1.33	0.44	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	67.41	43.39	0.00	0.36	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	15.57	23.96	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	47.85	36.88	1.26	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	48.53	25.10	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	55.68	32.46	0.41	0.62	0.21
Anulus Pulposus Cell, donor1	11248-116E6	11.67	12.59	0.34	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	20.57	18.61	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	32.80	13.03	0.45	0.45	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	38.64	17.37	0.00	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	23.54	14.98	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	31.98	12.85	0.00	0.90	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	15.18	2.53	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	18.48	8.58	0.66	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	30.86	14.62	0.00	0.97	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	38.84	16.50	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	22.57	8.31	0.00	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	28.25	12.81	0.38	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	33.38	13.06	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	8.78	0.00	1.25	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	20.59	15.16	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	32.76	6.82	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	21.41	9.50	0.15	0.30	0.30
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	41.26	15.00	0.00	1.07	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	37.41	13.04	0.00	0.76	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	28.87	11.23	0.53	0.27	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	43.90	10.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	34.17	12.11	0.17	0.50	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	28.82	7.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	7.08	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	33.45	11.66	0.17	0.17	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	8.39	16.78	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.27	14.08	0.97	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	32.25	14.04	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	23.02	16.96	0.00	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	27.93	10.83	0.00	0.00	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	33.78	13.90	0.43	0.64	0.64
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	20.65	10.32	0.77	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.97	9.38	0.00	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	23.15	11.90	0.32	0.00	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	19.26	6.42	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	28.08	11.70	0.00	0.58	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	33.42	13.55	0.00	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	19.01	9.50	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	34.07	12.21	0.51	1.02	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	34.38	10.44	0.25	1.02	0.76
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	6.99	0.00	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	33.23	16.40	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	32.18	10.80	0.21	0.64	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	19.72	10.73	0.58	0.29	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	30.23	14.17	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	36.79	11.87	0.17	0.51	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	14.79	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	34.09	13.51	0.43	1.07	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.06	11.43	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	32.80	10.21	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	34.02	10.80	0.23	1.15	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	15.30	0.00	2.55	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	23.64	13.98	0.00	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.55	12.80	0.21	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	25.40	10.71	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	27.25	11.47	0.00	1.91	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	34.37	15.52	0.22	1.11	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	19.84	13.73	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	23.26	11.63	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	28.60	9.80	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	21.08	8.72	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	51.95	53.06	1.23	0.49	0.37
Astrocyte - cerebellum, donor2	11580-120F5	62.64	57.68	0.00	0.17	1.03
Astrocyte - cerebellum, donor3	11661-122F5	25.80	18.04	0.63	0.21	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	35.56	34.16	2.09	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	73.12	43.19	2.10	0.49	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	85.02	50.42	2.09	2.09	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	41.63	34.06	2.18	0.46	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.24	38.71	1.75	0.63	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	38.12	35.05	1.71	0.80	0.34
Basophils, donor1	12241-129G9	18.31	9.15	0.00	0.52	0.00
Basophils, donor2	12242-129H1	27.78	8.66	0.36	0.72	0.00
Basophils, donor3	12243-129H2	22.93	7.64	0.00	0.00	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	9.27	14.45	0.65	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	19.20	19.20	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	47.70	23.85	0.00	0.63	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	43.67	32.02	0.83	0.00	0.42
Bronchial Epithelial Cell, donor6	11461-119B3	18.88	13.82	0.23	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	26.27	12.96	0.36	0.36	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	36.79	39.16	2.99	0.21	0.52
Burkitt's lymphoma cell line:RAJI	10476-106I8	30.04	33.54	2.10	0.23	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	37.41	34.22	1.92	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	10.34	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	15.78	12.40	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	18.00	9.47	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	19.10	10.32	0.44	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	24.62	22.36	0.57	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.82	17.82	0.76	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	26.30	19.07	0.66	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	69.96	20.82	0.43	1.30	1.45
CD14+ monocytes - mock treated, donor2	11873-125C1	46.47	11.47	0.30	0.00	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	86.23	24.40	0.00	0.71	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	21.26	7.70	0.00	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	20.98	4.69	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	17.11	4.21	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.07	1.37	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	6.59	2.14	0.36	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.19	4.13	0.22	0.22	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	18.26	2.34	0.23	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	13.73	7.39	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	12.20	4.44	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	25.29	9.97	0.15	0.15	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	18.76	4.99	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.40	7.29	0.21	0.00	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	22.19	3.66	0.46	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	19.23	3.85	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	19.64	6.98	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.87	7.26	0.00	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	15.35	5.06	0.70	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	20.20	7.57	0.42	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	8.27	1.47	0.00	0.18	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	6.69	1.41	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	7.02	1.75	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	7.85	3.14	0.00	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	10.41	2.97	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	11.64	3.23	0.43	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	13.51	5.32	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	11.82	3.71	0.00	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	11.37	3.25	0.23	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	47.95	22.23	0.65	0.00	1.31
CD14+CD16+ Monocytes, donor2	11801-124D1	28.41	18.48	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	34.66	25.13	0.43	0.22	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	23.51	17.91	0.31	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	19.04	15.37	0.87	0.17	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	37.90	20.51	0.67	0.22	0.67
CD14-CD16+ Monocytes, donor1	11790-124B8	34.96	21.43	0.00	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	29.20	16.91	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	40.64	18.95	1.05	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	28.45	26.42	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	23.73	20.34	3.39	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	22.78	12.43	4.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	13.33	12.26	3.73	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	13.40	17.69	2.14	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	27.38	11.93	2.81	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	19.61	29.81	0.78	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	22.41	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	41.10	23.01	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	26.12	21.76	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	44.93	20.70	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	212.53	135.76	2.02	1.62	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	168.19	108.26	1.60	0.40	0.80
CD34+ Progenitors, donor1	11545-120B6	14.06	16.06	1.00	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	22.47	15.17	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	38.70	39.08	4.13	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	42.39	41.71	2.71	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	5.71	7.14	0.36	0.36	0.00
CD4+ T Cells, donor2	11306-117C1	9.19	11.02	0.61	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	16.16	18.91	1.52	0.00	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	17.36	34.46	3.06	0.00	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	14.60	40.88	4.04	0.00	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	14.37	34.50	1.72	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1.90	9.48	1.90	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	1.40	3.51	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	16.48	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	20.23	28.76	3.47	0.72	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	31.52	39.48	3.22	0.85	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	34.50	41.59	2.90	0.32	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	12.10	23.76	2.24	0.90	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	22.71	37.73	2.80	0.35	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	21.56	36.52	3.08	0.88	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	11.38	38.37	2.53	0.84	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	29.30	34.91	3.12	0.62	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	26.73	38.76	0.67	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.82	4.62	0.54	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	3.75	4.29	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	8.97	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	29.48	46.91	3.52	0.37	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	25.99	42.46	3.47	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	29.63	44.76	2.10	0.00	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	14.16	15.67	2.02	0.51	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	5.63	17.76	3.47	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	17.00	17.43	3.49	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	14.85	23.75	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	12.00	21.23	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	19.54	23.73	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	19.11	27.42	1.38	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	21.84	35.09	0.98	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	12.32	32.34	1.54	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.20	22.92	3.94	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	31.85	22.16	4.15	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	9.17	8.84	0.33	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	7.51	6.38	0.38	0.00	0.38
CD8+ T Cells, donor3	11383-118B6	9.85	6.31	1.01	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	31.66	21.79	0.46	0.92	1.61
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	24.44	21.81	0.96	0.72	0.72
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.00	25.72	1.37	0.82	1.37
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	36.33	20.71	0.30	0.90	1.80
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.64	25.68	1.92	0.72	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	33.88	23.65	0.68	0.91	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	26.94	23.47	0.87	0.87	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	29.48	24.21	0.00	0.79	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	28.61	25.80	0.47	0.94	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	28.68	23.55	1.21	0.00	1.81
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	22.66	20.63	0.29	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	30.64	22.65	0.53	0.53	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	26.70	14.45	0.88	0.44	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	29.60	17.31	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	23.87	14.17	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	33.85	26.29	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	27.33	18.41	0.58	0.58	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.69	24.51	1.41	0.47	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	43.10	24.40	0.95	0.63	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	30.14	27.07	0.31	0.31	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	30.78	17.63	1.92	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	20.27	20.27	0.38	1.15	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	29.56	16.95	0.39	0.00	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	24.96	17.40	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	26.50	8.83	0.80	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.18	12.59	0.00	0.70	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	41.07	14.02	0.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	63.97	38.38	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	69.17	20.75	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	32.73	20.31	1.05	0.32	0.11
Chondrocyte - de diff, donor1	11261-116G1	69.33	39.52	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	26.30	14.93	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	54.16	18.89	0.23	1.25	0.68
Chondrocyte - re diff, donor2	11339-117F7	47.45	22.38	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	25.07	12.94	0.00	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	35.46	29.26	1.26	0.34	0.69
Ciliary Epithelial Cells, donor2	11323-117D9	31.21	18.17	1.07	0.86	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	40.35	23.54	0.62	0.44	0.53
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	104.08	58.41	1.56	1.10	0.28
Corneal Epithelial Cells, donor1	11526-119I5	21.96	25.03	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	11.38	21.61	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	35.02	29.40	1.79	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	43.42	22.62	0.17	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	43.53	18.92	0.32	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	20.70	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	75.16	22.46	0.54	0.86	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2.73	7.52	0.34	0.34	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	8.49	15.02	1.96	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	4.36	9.19	1.45	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	32.52	24.52	1.17	0.33	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	51.64	25.82	0.59	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	43.83	33.37	0.28	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	32.24	32.24	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	45.96	19.49	0.29	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	53.41	29.17	0.71	0.94	2.12
Endothelial Cells - Artery, donor3	11413-118E9	46.11	36.11	0.53	0.53	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	33.03	23.72	1.33	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	35.90	20.99	0.91	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.88	29.04	2.26	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	53.78	34.47	0.59	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	45.30	25.51	1.56	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	45.23	24.39	0.28	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	65.62	56.42	0.40	1.20	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	39.83	19.39	0.52	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	52.80	45.35	2.73	0.62	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	61.70	52.58	1.52	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	80.73	64.48	3.18	0.73	0.24
Endothelial Cells - Vein, donor1	11267-116G7	37.54	26.16	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	38.42	33.53	2.10	0.70	0.70
Endothelial Cells - Vein, donor3	11416-118F3	54.17	29.83	1.10	0.47	0.31
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	14.85	9.90	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	10.70	17.83	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.77	17.84	0.00	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	20.80	8.32	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	32.54	32.54	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	91.96	29.97	0.41	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	23.10	7.01	0.11	0.99	0.77
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	46.80	31.31	0.54	1.19	1.63
Fibroblast - Aortic Adventitial, donor1	11245-116E3	56.27	30.68	0.97	0.85	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	17.74	9.42	0.27	0.14	0.14
Fibroblast - Aortic Adventitial, donor2	11326-117E3	37.34	15.82	0.21	0.21	0.74
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	24.50	20.29	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	76.74	37.54	1.66	0.33	2.33
Fibroblast - Cardiac, donor1	11268-116G8	64.87	25.86	0.45	1.36	1.81
Fibroblast - Cardiac, donor2	11345-117G4	45.48	15.16	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	40.22	9.94	0.47	0.32	0.32
Fibroblast - Cardiac, donor4	11452-119A3	29.10	23.34	1.82	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	55.96	31.98	0.13	0.51	0.13
Fibroblast - Cardiac, donor6	11460-119B2	56.54	30.77	0.76	0.61	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.59	23.45	0.67	0.40	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	26.75	18.12	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	55.66	49.80	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	21.22	31.83	0.69	0.23	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	16.62	12.89	1.19	0.17	0.17
Fibroblast - Dermal, donor1	11269-116G9	25.36	18.55	0.94	0.00	0.00
Fibroblast - Dermal, donor2	11346-117G5	35.38	43.39	0.94	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	20.07	17.65	0.24	0.00	0.24
Fibroblast - Dermal, donor4	11450-119A1	50.42	50.19	0.45	0.68	0.68
Fibroblast - Dermal, donor5	11454-119A5	66.29	59.49	1.22	0.35	1.22
Fibroblast - Dermal, donor6	11458-119A9	81.70	77.48	1.30	0.81	0.97
Fibroblast - Gingival, donor1	11237-116D4	17.70	21.66	1.87	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	61.83	30.65	0.52	1.05	0.79
Fibroblast - Gingival, donor2	11318-117D4	61.28	43.09	1.71	0.92	0.40
Fibroblast - Gingival, donor3	11394-118C8	21.66	19.72	1.16	0.10	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	19.74	18.70	1.04	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	27.84	14.45	0.53	0.35	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	71.40	46.61	1.25	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	57.34	42.87	1.22	0.81	1.08
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	63.17	52.93	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	60.40	42.26	1.90	0.58	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	72.81	40.63	1.64	0.27	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	109.58	54.19	1.21	0.99	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.54	10.27	0.29	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	25.83	13.59	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	23.87	23.87	1.49	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	44.32	42.84	1.06	0.63	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	44.15	88.30	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	36.36	37.76	1.40	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	17.91	21.55	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	56.84	56.84	4.47	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	43.94	47.93	3.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	53.61	17.87	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	36.08	45.00	3.10	0.58	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	64.01	54.76	1.52	0.61	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	37.94	41.61	2.45	0.61	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	79.00	33.20	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	50.22	23.49	0.27	0.54	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	40.59	19.95	0.46	0.46	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	74.06	32.16	1.22	0.99	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	51.00	41.65	1.83	0.41	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	51.45	36.75	1.34	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.07	16.61	1.19	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	52.79	31.35	0.20	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	21.67	12.26	0.36	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	33.31	14.98	0.39	0.00	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.92	24.97	0.30	0.30	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	54.62	29.69	0.11	0.11	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	37.20	14.43	0.00	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	38.39	23.96	0.49	0.33	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	51.73	27.47	0.20	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	88.31	40.18	0.40	0.40	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	42.92	22.37	0.30	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	24.19	15.16	0.25	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	48.89	26.33	0.34	0.17	0.85
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	40.40	21.35	0.33	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	97.25	38.13	0.53	0.75	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	65.11	39.64	1.01	0.51	0.84
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	75.12	23.99	0.63	3.29	2.51
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	664.79	332.40	22.16	88.64	132.96
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	55.78	34.86	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	63.10	32.07	0.17	0.35	0.87
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	62.20	20.30	1.30	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	76.14	32.96	0.26	0.00	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	83.45	75.79	1.53	1.53	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	74.02	80.40	1.28	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	120.67	76.17	5.42	1.71	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	51.02	38.61	0.83	0.28	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	54.57	26.94	1.14	0.00	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	74.30	59.24	3.76	0.40	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	45.20	34.89	2.64	0.53	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	51.53	26.74	1.30	0.65	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	84.91	69.87	2.65	2.21	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	88.19	85.92	5.65	0.71	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	93.83	68.71	3.08	1.35	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	82.20	65.28	5.10	0.81	1.34
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	127.98	87.10	3.59	0.50	0.87
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	137.32	95.79	3.18	1.80	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	97.18	64.04	3.25	2.03	2.03
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	70.05	45.64	0.91	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	94.79	74.99	1.74	1.12	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	94.86	69.51	2.40	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	61.46	36.34	1.48	0.00	0.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	88.86	53.25	1.75	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	58.31	42.67	1.12	0.45	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	64.52	36.50	1.21	0.60	1.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	94.83	54.46	1.19	0.85	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	53.38	47.79	2.04	0.62	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	36.84	39.23	1.87	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	37.74	38.77	1.20	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	68.72	43.93	1.00	0.55	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.01	38.44	2.08	0.33	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	49.41	40.63	1.23	0.20	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	41.47	34.66	1.44	0.21	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	54.65	38.85	1.61	0.81	0.35
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	57.70	27.02	1.17	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	37.91	27.33	1.10	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	61.62	33.58	1.23	0.86	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	51.87	23.18	0.49	0.32	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	38.81	24.70	0.96	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	65.48	35.44	0.66	0.28	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	42.71	22.46	0.95	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	35.58	25.24	0.61	0.30	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	58.02	33.03	0.63	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	41.06	21.74	0.00	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	48.82	21.88	0.56	0.56	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	50.18	28.70	0.56	0.37	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	40.91	18.99	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	68.85	25.40	0.46	1.07	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	73.06	26.30	0.52	0.91	0.52
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.16	15.45	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	41.29	21.02	0.74	0.55	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	39.91	17.76	0.88	0.44	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	57.52	14.88	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	41.68	17.94	0.53	0.26	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.48	16.14	0.40	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	37.11	31.26	1.52	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	112.67	102.91	3.18	1.59	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	91.52	82.74	6.78	1.85	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	122.14	124.80	7.16	1.64	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	93.88	72.91	4.07	1.25	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	79.12	76.86	3.96	1.41	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	113.46	95.93	6.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	76.72	66.82	2.47	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	114.88	60.73	1.16	1.55	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	102.69	91.45	0.00	3.21	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	99.11	59.12	1.74	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	93.09	50.45	1.63	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	90.18	61.36	0.00	0.82	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	96.64	43.32	0.00	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	73.27	48.94	2.52	1.12	1.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	82.36	55.24	0.65	1.63	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	53.69	44.46	2.52	0.00	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	78.56	41.67	0.95	0.64	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	66.23	47.55	2.38	1.70	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	54.29	2.09	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	65.29	68.72	0.57	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	57.42	41.14	0.59	0.59	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	50.82	33.88	0.00	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	91.54	36.45	0.83	2.90	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	72.03	39.58	0.46	0.69	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	21.07	5.27	0.00	10.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	58.43	27.29	1.15	0.38	1.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	56.39	32.92	1.30	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	42.81	32.10	2.01	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	52.01	29.67	0.39	0.77	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	85.58	23.96	0.34	2.05	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	37.27	34.79	2.48	2.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	49.54	42.47	2.83	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	48.28	30.17	1.21	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	50.87	31.54	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	50.65	29.91	1.60	0.80	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	52.79	28.12	0.99	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	60.20	36.59	1.18	3.54	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	50.18	32.09	0.58	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	49.15	33.79	0.88	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	37.30	33.06	1.70	0.00	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	37.01	27.46	0.60	1.79	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	38.33	21.35	0.00	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	17.12	21.68	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	22.04	12.06	0.42	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	33.73	0.00	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	24.42	12.37	0.63	0.63	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	18.80	7.94	0.42	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	37.95	29.47	0.46	0.12	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	41.36	34.60	1.18	1.18	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	39.81	23.89	0.46	0.23	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	35.63	26.45	0.98	0.33	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	37.39	28.58	0.86	0.43	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	35.09	26.26	0.86	0.22	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	30.89	19.43	0.62	0.50	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	32.42	20.93	0.69	0.69	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.03	18.26	0.64	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	55.40	55.40	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	45.01	27.27	0.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	55.52	23.79	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	36.68	29.98	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.23	26.88	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	64.17	34.97	0.87	1.05	0.87
Hepatocyte, donor1	11523-119I2	64.16	19.37	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	76.49	31.24	0.00	2.15	1.08
Hepatocyte, donor3	11684-122I1	55.22	26.38	1.84	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	31.98	37.20	0.65	0.65	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	31.99	17.30	1.05	0.17	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	32.38	25.38	1.37	0.00	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	25.47	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	13.35	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	51.22	22.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	17.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	71.21	47.47	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	69.20	2.56	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	22.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	73.09	17.87	0.00	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	43.35	25.01	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	61.72	14.52	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	56.91	29.12	0.00	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	66.52	29.93	0.00	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	52.38	20.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	66.14	30.23	0.63	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	54.13	13.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	65.90	26.49	0.65	1.94	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	53.13	22.54	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	77.41	24.45	0.81	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	39.88	21.41	0.42	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	43.12	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	75.55	31.34	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	61.86	22.16	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	75.40	45.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	64.20	25.02	0.00	1.89	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	51.70	19.05	0.00	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	117.94	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	61.34	27.98	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	57.17	15.25	1.27	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	115.01	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	64.41	33.80	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	65.62	20.05	0.00	0.00	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	79.02	15.80	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	60.70	19.99	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	19.91	0.00	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	66.98	26.24	0.62	0.93	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	52.68	22.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	59.72	37.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	70.93	38.25	0.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	46.47	11.07	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	32.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	48.83	23.54	0.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	42.75	18.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	48.78	0.00	0.00	3.48	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	52.27	13.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	13.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	45.59	19.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	56.15	31.29	1.84	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	60.51	15.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	24.83	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	47.58	16.92	0.00	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	29.87	18.69	0.82	0.33	0.41
Keratinocyte - epidermal, donor2	11349-117G8	14.64	12.88	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	53.39	26.79	0.76	0.66	0.47
Keratinocyte - oral, donor1	11251-116E9	32.35	29.06	2.04	0.34	0.68
Keratocytes, donor1	11527-119I6	23.04	22.01	0.00	0.34	0.00
Keratocytes, donor2	11607-120I5	26.95	35.15	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	16.01	12.45	0.40	0.40	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	276.94	37.36	4.40	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	50.70	30.20	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	33.68	20.18	0.58	0.35	0.23
Lens Epithelial Cells, donor3	11690-122I7	31.79	20.28	1.01	0.20	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	40.79	25.49	0.71	0.59	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	23.16	25.95	0.00	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	29.91	21.09	0.79	0.63	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	38.72	27.96	0.00	0.54	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.21	29.63	0.63	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	28.79	18.87	0.86	0.32	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	37.35	15.59	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	25.03	23.01	1.01	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.49	19.28	0.42	0.42	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.99	23.34	0.40	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.61	28.69	0.97	0.39	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.59	14.81	0.37	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	41.81	18.47	0.70	1.39	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	22.90	26.24	0.24	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	27.74	19.50	0.41	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	32.64	23.71	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	19.64	21.20	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	26.17	18.85	0.37	0.55	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	26.66	27.97	0.00	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	17.87	28.70	0.88	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	22.40	18.17	0.00	0.50	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	36.86	24.25	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	28.28	22.62	0.54	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	33.91	16.50	0.61	0.45	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	33.70	17.11	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	28.27	25.34	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.37	20.45	0.30	0.75	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.83	30.27	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	29.54	21.45	1.13	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	31.81	18.03	0.32	0.11	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	34.41	25.20	0.97	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	21.17	27.12	0.99	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	26.14	17.59	0.50	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	38.87	20.36	1.11	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	24.21	23.23	1.24	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	29.97	17.46	0.55	0.41	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	35.38	23.80	1.29	0.64	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.35	28.61	0.30	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	31.21	22.81	0.42	0.14	0.70
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	38.76	19.56	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.78	25.69	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	19.76	15.09	0.62	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	33.66	27.93	0.72	0.72	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	29.73	29.07	0.98	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.78	16.72	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	42.82	28.83	0.99	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	28.17	21.00	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.43	19.99	0.30	0.60	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	33.99	38.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	35.29	14.58	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	24.49	21.52	0.74	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	27.08	21.16	0.42	0.42	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.02	14.07	0.00	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	28.02	8.41	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	18.03	17.00	0.52	2.58	1.55
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	38.06	17.84	1.19	1.19	4.76
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	26.69	18.55	1.81	0.90	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	24.14	18.32	0.29	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	34.66	18.46	2.25	0.90	1.35
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	24.66	21.14	0.54	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	24.14	17.46	0.51	1.54	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	35.99	20.82	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	21.99	14.66	1.33	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	24.96	21.39	0.51	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	38.69	21.08	0.53	0.53	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	36.09	16.44	0.38	0.57	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	33.13	23.32	0.61	1.84	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	59.53	18.75	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	37.69	18.12	1.67	0.21	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	31.39	20.74	0.56	0.84	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	38.12	20.61	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	38.61	16.55	1.74	0.29	2.03
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	24.51	20.93	0.90	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	48.69	21.58	0.00	0.55	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	36.41	20.15	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	30.61	21.02	0.74	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	17.27	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	41.45	18.42	1.54	1.15	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	30.00	22.08	1.13	0.57	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	33.64	17.23	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	42.48	20.79	3.16	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	25.85	17.95	0.00	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	37.35	16.43	1.49	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	40.88	24.53	1.11	1.11	1.49
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	25.41	21.97	0.00	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	39.39	22.26	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.32	20.99	0.67	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.96	18.70	1.21	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	33.42	22.75	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	37.12	23.03	0.34	1.72	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	26.30	20.93	0.54	0.54	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	26.93	23.57	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	31.48	20.74	0.37	0.74	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	25.58	15.12	0.00	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	27.50	21.15	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	40.02	18.01	0.80	1.60	2.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	41.43	31.98	1.45	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	40.63	13.80	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	52.29	22.69	2.96	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	22.58	0.94	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	45.25	17.60	1.51	1.51	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	42.36	20.73	1.80	0.45	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	20.65	30.98	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	33.85	17.81	0.89	0.45	1.78
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	47.31	22.29	0.00	0.00	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	33.65	25.07	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	40.48	18.16	2.08	1.56	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	49.88	25.38	0.88	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	29.63	17.33	0.00	0.00	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	50.79	18.11	0.44	0.44	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	43.97	25.46	0.77	0.77	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	32.91	23.80	2.03	1.01	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	39.89	13.46	0.96	0.96	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	37.37	19.88	0.40	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	30.99	25.52	1.22	1.22	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.89	22.83	0.69	2.77	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	42.18	16.34	1.14	1.14	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.82	13.43	0.52	0.00	2.58
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.84	27.81	0.00	1.81	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	30.74	21.23	0.95	0.63	1.27
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	34.65	19.72	0.53	1.07	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	33.91	20.69	0.00	1.15	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	39.60	21.08	1.03	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	33.95	25.46	0.00	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	36.32	23.27	1.13	2.27	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	43.27	14.14	1.25	1.25	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	25.06	21.14	0.78	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	36.74	23.80	0.00	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	46.00	21.37	0.46	1.39	1.39
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	29.44	24.75	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	42.24	25.13	0.00	0.53	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	54.96	18.99	0.81	1.21	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	25.70	26.62	0.92	0.92	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.90	29.34	0.00	1.78	1.78
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.17	20.52	2.28	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	43.71	19.17	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.40	24.08	0.00	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	49.44	16.48	1.34	0.89	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	32.75	18.46	1.56	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	39.12	28.51	1.99	0.00	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	37.41	43.65	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	73.39	32.14	1.14	0.91	0.23
Macrophage - monocyte derived, donor2	11313-117C8	30.28	17.25	0.92	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	105.65	34.08	1.05	0.39	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	71.16	29.21	2.12	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	58.63	18.06	0.63	0.16	0.95
Mallassez-derived cells, donor3	11930-125I4	79.22	41.97	0.97	0.28	0.56
Mammary Epithelial Cell, donor1	11273-116H4	34.48	28.30	0.70	0.30	0.10
Mammary Epithelial Cell, donor2	11350-117G9	41.70	29.24	0.58	0.00	0.58
Mammary Epithelial Cell, donor3	11422-118F9	48.39	32.92	0.75	0.75	0.50
Mast cell - stimulated, donor1	11487-119E2	73.90	30.51	0.68	0.00	0.68
Mast cell, donor1	11563-120D6	21.30	18.49	0.54	0.00	0.11
Mast cell, donor2	11565-120D8	26.45	23.18	2.08	0.59	0.30
Mast cell, donor3	11566-120D9	39.62	31.29	2.25	0.68	0.23
Mast cell, donor4	11567-120E1	36.34	29.43	1.95	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	24.95	13.97	0.44	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	12.84	7.00	0.00	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	33.96	31.78	1.03	0.34	0.46
Mast cell, expanded, donor8	11941-126A6	22.76	16.40	0.84	0.17	0.17
Melanocyte - dark, donor1	11502-119F8	60.49	50.05	1.59	0.40	0.40
Melanocyte - dark, donor2	11582-120F7	68.18	23.88	0.69	0.69	0.69
Melanocyte - dark, donor3	11663-122F7	52.95	28.32	0.80	0.14	0.29
Melanocyte - light, donor1	11274-116H5	19.51	13.16	0.71	0.24	0.71
Melanocyte - light, donor2	11351-117H1	21.16	20.47	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	37.29	13.88	0.87	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	89.65	33.94	1.67	0.83	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	44.64	22.86	0.81	0.81	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	48.21	22.77	0.00	0.27	0.54
Meningeal Cells, donor1	11493-119E8	79.27	104.46	1.12	0.25	0.00
Meningeal Cells, donor2	11573-120E7	59.42	52.82	1.32	0.00	0.44
Meningeal Cells, donor3	11654-122E7	62.67	64.39	2.93	0.49	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	31.65	37.07	0.86	0.57	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	16.20	9.46	0.00	0.10	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	2.63	3.94	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	36.63	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	58.13	49.51	1.44	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.71	14.61	0.21	0.00	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	39.71	29.15	0.50	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	33.62	43.29	0.66	0.44	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	54.79	63.56	1.46	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	50.95	47.47	0.61	0.41	0.82
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.71	21.05	0.42	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	8.55	12.64	0.00	0.37	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	12.89	11.45	1.05	0.26	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	8.90	4.45	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	11.68	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	36.50	28.82	1.28	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	54.94	42.89	1.06	0.71	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	10.01	11.26	0.63	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	44.99	37.01	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	17.50	12.20	0.80	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	32.03	12.51	1.50	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	29.92	12.21	0.43	0.36	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	144.48	54.01	4.05	0.00	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	80.53	26.84	0.49	0.00	0.99
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.28	24.15	1.18	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	107.17	69.14	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	54.24	19.84	0.31	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	34.23	22.82	0.62	0.41	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	81.06	44.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	55.81	20.52	0.00	0.50	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	46.55	30.26	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	155.73	58.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	45.32	17.88	0.41	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	33.66	21.78	0.00	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	179.58	42.76	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	50.44	16.81	0.00	0.88	1.77
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	24.70	20.52	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	69.74	36.85	2.63	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	36.29	14.86	0.21	0.00	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	34.07	28.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	43.22	13.11	0.89	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	78.80	65.39	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	237.65	169.75	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	38.89	19.07	1.25	0.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	31.85	19.49	0.48	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	49.76	33.17	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	35.69	11.97	0.69	0.23	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	25.45	17.46	0.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	39.54	10.80	0.61	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	36.26	9.23	0.43	0.64	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.68	18.89	0.22	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	103.18	82.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.57	12.48	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	67.43	35.49	1.01	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	67.94	48.05	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	48.92	15.76	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	36.17	22.35	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	79.59	26.17	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	27.39	10.57	0.00	0.48	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.42	22.01	0.40	0.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	148.09	35.65	1.37	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	31.54	13.52	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	185.50	44.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	36.35	17.08	0.88	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	167.76	71.74	1.10	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	142.17	48.03	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	41.90	16.36	0.74	0.25	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	116.91	38.27	1.39	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	209.94	59.67	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	43.42	18.46	0.68	0.68	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	129.10	46.82	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	148.79	59.66	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	53.59	23.01	0.28	0.84	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	83.13	46.97	0.83	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	129.37	44.29	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	56.11	22.32	0.60	0.60	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	65.53	35.48	0.42	0.42	1.25
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	144.38	101.06	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	60.03	24.01	2.77	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	95.61	39.27	0.57	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	65.08	28.47	0.97	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.80	26.43	1.04	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	85.80	42.47	1.29	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	102.27	37.48	1.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	43.24	21.35	1.33	0.00	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	37.42	24.25	1.20	0.00	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	27.69	18.08	0.71	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	33.13	26.76	0.96	0.32	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	69.21	34.72	1.11	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	67.88	22.37	2.65	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	32.10	16.19	0.28	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	43.75	25.32	0.49	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	35.84	21.51	1.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.17	14.70	0.88	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.16	18.74	0.86	0.29	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	19.37	16.07	1.65	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	20.84	13.10	0.60	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	48.97	26.37	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	37.43	7.13	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	78.20	13.80	0.66	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	16.83	0.00	1.05	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	25.90	12.65	0.00	0.79	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	39.12	16.76	0.93	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	58.21	28.16	1.13	0.00	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	25.84	17.05	0.00	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	57.91	17.42	0.90	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	17.68	16.94	0.00	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	68.15	18.32	1.10	0.37	1.47
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	68.45	18.67	1.56	0.00	4.67
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	53.44	14.43	0.00	0.53	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	59.59	24.24	2.02	1.01	2.02
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	44.69	20.24	0.42	0.00	1.26
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	34.05	12.26	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	23.52	10.17	0.64	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	39.68	12.96	0.00	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	9.06	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	22.84	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	42.41	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	33.27	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	59.68	35.12	0.43	0.00	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	50.69	32.92	0.52	0.52	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	31.37	28.03	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	65.11	29.63	0.42	0.42	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	46.96	22.25	0.00	0.76	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	169.16	84.58	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	9.52	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	58.80	18.38	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	15.07	20.51	1.67	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	37.66	24.64	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	16.21	18.11	0.81	0.54	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	27.54	20.60	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	33.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	14.39	12.41	0.99	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	12.18	4.60	0.00	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	14.05	12.47	0.00	0.23	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	14.70	11.10	0.33	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	21.87	11.12	0.36	0.55	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	12.20	14.32	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	13.81	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	11.16	8.53	0.33	0.66	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	12.20	12.36	0.16	0.16	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	25.05	13.23	0.18	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.85	12.66	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	20.23	17.01	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	14.14	8.68	0.00	0.32	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	19.31	6.55	0.00	1.38	0.69
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	106.19	22.76	5.06	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	20.94	16.26	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	14.40	13.13	0.85	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.23	9.02	0.47	0.00	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.45	14.17	0.43	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	72.22	54.17	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.66	8.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	30.66	15.78	0.45	0.00	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.49	11.51	0.79	0.40	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	10.22	9.29	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	16.65	5.68	0.00	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	24.44	14.99	0.33	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.17	10.46	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	49.75	13.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	18.52	14.11	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	13.30	12.63	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	9.92	12.90	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	31.39	15.31	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	12.10	6.05	0.30	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	32.05	13.48	0.00	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	22.36	7.45	0.00	0.00	1.36
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	20.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	14.63	12.80	0.00	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	35.25	15.11	0.00	0.63	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.55	14.53	1.21	0.00	0.61
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	22.94	9.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	23.81	4.53	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	30.35	25.29	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	41.62	16.90	0.37	0.50	0.37
Myoblast, donor2	11322-117D8	28.38	16.30	0.38	0.77	0.19
Myoblast, donor3	11398-118D3	36.15	22.87	0.67	0.34	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	63.04	28.31	0.58	0.29	0.88
Natural Killer Cells, donor1	11230-116C6	12.61	11.07	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	11.46	6.03	0.00	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	13.25	7.73	0.55	0.18	0.55
Neural stem cells, donor1	11275-116H6	38.11	27.95	0.36	0.00	0.36
Neural stem cells, donor2	11352-117H2	102.06	82.80	3.85	0.00	0.00
Neurons, donor1	11494-119E9	221.89	64.86	2.28	2.28	3.41
Neurons, donor2	11574-120E8	84.10	66.71	2.64	0.88	0.88
Neurons, donor3	11655-122E8	174.30	59.20	1.64	4.93	3.29
Neutrophils, donor1	11233-116C9	8.35	5.57	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	14.49	5.80	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	19.55	10.38	0.00	0.61	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	13.30	11.40	0.12	0.00	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	15.30	15.95	0.33	0.98	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	21.46	24.47	0.00	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	38.96	19.13	0.55	0.55	0.41
Olfactory epithelial cells, donor2	11934-125I8	58.33	20.41	0.29	0.87	1.88
Olfactory epithelial cells, donor3	11935-125I9	48.24	25.88	0.57	0.79	0.45
Olfactory epithelial cells, donor4	11936-126A1	52.30	33.41	0.68	0.39	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	71.01	31.29	1.81	0.60	0.60
Osteoblast - differentiated, donor1	11276-116H7	30.42	18.29	0.21	0.64	0.00
Osteoblast - differentiated, donor2	11353-117H3	32.01	20.58	0.00	0.00	3.43
Osteoblast - differentiated, donor3	11425-118G3	26.69	19.86	0.62	0.62	0.00
Osteoblast, donor1	11277-116H8	25.99	26.58	0.59	0.20	0.59
Osteoblast, donor2	11354-117H4	83.58	53.38	0.00	0.00	0.70
Osteoblast, donor3	11426-118G4	79.98	38.03	1.07	0.71	0.18
Pancreatic stromal cells, donor1	11249-116E7	40.43	25.52	0.93	0.51	0.76
Pericytes, donor1	11491-119E6	9.68	15.58	0.22	0.00	0.11
Pericytes, donor2	11571-120E5	16.30	13.36	0.00	0.00	0.00
Pericytes, donor3	11652-122E5	55.75	30.31	0.20	0.81	0.41
Perineurial Cells, donor1	11499-119F5	37.41	29.95	1.58	0.00	0.11
Perineurial Cells, donor2	11579-120F4	56.95	26.50	1.10	0.09	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	18.49	16.26	0.96	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	22.53	10.04	0.24	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	15.27	9.58	0.52	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	28.94	16.50	0.72	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	28.83	22.18	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	33.38	17.28	0.98	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	70.25	23.42	0.32	3.48	5.38
Preadipocyte - breast, donor1	11467-119B9	31.89	23.45	0.19	0.38	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	32.89	12.27	0.39	0.26	0.00
Preadipocyte - breast, donor2	11328-117E5	75.42	22.06	0.68	0.45	3.38
Preadipocyte - omental, donor1	11468-119C1	48.27	29.30	1.07	0.11	0.64
Preadipocyte - omental, donor2	11329-117E6	56.74	26.62	0.44	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	67.47	30.08	0.43	0.57	0.72
Preadipocyte - perirenal, donor1	11469-119C2	61.02	31.50	0.00	0.98	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	16.89	13.21	0.61	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	62.15	42.68	1.42	1.06	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	41.89	21.12	0.17	0.00	0.17
Preadipocyte - visceral, donor1	11280-116I2	36.05	38.75	1.58	0.19	0.19
Preadipocyte - visceral, donor2	11357-117H7	36.35	35.43	0.92	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	55.69	36.68	0.52	0.52	1.15
Prostate Epithelial Cells (polarized), donor1	11253-116F2	39.22	18.10	1.06	0.30	0.30
Prostate Epithelial Cells, donor2	11331-117E8	50.64	23.43	0.81	0.54	1.49
Prostate Epithelial Cells, donor3	11404-118D9	27.31	12.00	0.24	0.12	0.31
Prostate Stromal Cells, donor1	11254-116F3	60.14	31.09	1.03	0.46	0.57
Prostate Stromal Cells, donor2	11332-117E9	77.64	43.03	1.61	0.36	1.61
Prostate Stromal Cells, donor3	11405-118E1	38.79	24.71	0.31	0.10	0.42
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.97	51.46	2.92	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	53.09	35.56	1.59	1.04	0.28
Renal Epithelial Cells, donor1	11517-119H5	53.77	50.72	1.01	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	61.17	55.48	0.71	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	41.50	34.72	1.91	0.53	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	64.00	57.19	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	93.26	65.50	0.81	0.94	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	124.99	56.83	0.22	1.55	0.89
Renal Glomerular Endothelial Cells, donor4	11783-124B1	21.96	11.31	1.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	41.16	45.78	1.32	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	53.29	57.68	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	31.35	34.40	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	74.35	81.33	3.49	0.00	0.81
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	67.05	47.65	2.95	0.42	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	84.66	59.98	1.54	0.77	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	22.30	27.74	1.04	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	20.75	19.04	1.71	0.00	0.57
Retinal Pigment Epithelial Cells, donor2	11608-120I6	29.84	31.90	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	17.81	20.32	1.25	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	36.75	24.32	0.94	0.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	37.52	15.19	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	15.96	4.40	0.55	0.00	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.70	15.08	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	55.26	28.35	0.52	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	45.58	22.84	1.09	0.79	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	37.81	19.18	0.56	0.67	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	72.94	25.43	1.12	0.62	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	45.22	19.11	0.58	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	59.63	20.34	0.92	0.00	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	57.78	24.78	0.41	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	46.89	16.94	0.91	0.15	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	40.14	21.14	0.72	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	52.07	21.09	0.29	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	43.68	17.49	0.54	0.32	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	54.65	20.14	0.89	0.44	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	57.16	26.57	0.00	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	48.72	17.98	0.75	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	35.89	21.99	1.13	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	73.12	28.27	0.66	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	51.59	20.15	0.97	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	47.93	20.43	0.19	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	67.49	24.67	0.11	0.11	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	45.97	17.38	0.84	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	60.84	21.02	1.20	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	67.28	22.79	0.00	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	45.01	20.23	0.49	0.37	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	58.03	23.24	0.94	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	51.18	30.66	0.24	0.47	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	46.03	15.67	0.60	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	58.23	25.26	1.64	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	57.02	25.09	0.83	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	43.14	19.47	0.88	1.11	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	57.44	26.95	0.84	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	65.41	29.88	0.27	0.40	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	65.39	25.03	1.19	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	67.67	26.80	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	60.18	25.62	0.34	0.69	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.02	24.69	0.82	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	55.98	24.13	0.66	0.99	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	51.30	24.03	0.17	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	49.86	23.67	1.33	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	55.71	18.66	0.80	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	43.28	17.97	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	38.57	14.05	0.24	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	56.23	18.54	1.21	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	42.66	18.83	0.00	0.19	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	37.73	13.97	0.70	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	45.03	14.20	0.60	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	47.98	18.24	0.49	0.12	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	38.43	16.59	0.58	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	47.46	18.25	0.61	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	49.43	18.08	0.30	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	35.96	14.02	0.23	0.45	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	44.93	17.97	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	38.61	15.70	0.12	0.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	34.15	14.09	1.07	0.43	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	37.26	13.82	1.80	0.60	0.00
Schwann Cells, donor1	11498-119F4	44.20	49.09	0.56	0.00	0.00
Schwann Cells, donor2	11578-120F3	64.65	44.23	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	56.96	40.31	0.88	1.10	0.88
Sebocyte, donor1	11220-116B5	59.71	30.13	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	49.63	27.11	0.92	0.46	0.46
Sebocyte, donor3	11378-118B1	21.85	12.99	1.24	0.00	0.00
Sertoli Cells, donor1	11255-116F4	84.49	56.32	3.31	1.66	1.66
Sertoli Cells, donor2	11333-117F1	50.84	25.42	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	17.07	21.73	0.44	0.35	0.00
Skeletal Muscle Cells, donor2	11358-117H8	6.51	5.78	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	60.19	38.46	0.84	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	44.46	43.36	0.63	1.10	0.31
Skeletal Muscle Cells, donor5	11455-119A6	39.54	41.32	0.89	0.30	0.59
Skeletal Muscle Cells, donor6	11459-119B1	66.02	56.17	1.08	1.08	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.16	25.96	1.64	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	28.97	24.83	1.28	0.43	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	63.00	45.14	1.69	0.60	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.86	14.58	0.42	0.25	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	53.56	24.61	0.72	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	22.84	17.89	0.00	0.55	0.55
Skin - palm, donor1	10286-104F7	91.33	42.98	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	27.39	16.29	0.14	1.30	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	20.45	7.36	0.00	0.00	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	30.25	19.86	0.78	1.04	1.17
Small Airway Epithelial Cells, donor1	11256-116F5	29.75	12.65	0.28	0.70	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	50.07	15.05	0.70	0.28	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	29.39	19.24	0.21	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	44.60	14.77	0.30	0.22	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	57.71	28.39	0.31	0.93	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	21.57	11.12	0.00	0.22	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	23.51	22.93	0.59	0.00	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	48.18	23.65	0.66	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	29.93	19.69	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	23.95	27.81	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	8.01	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.08	18.63	0.13	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	34.80	24.83	0.44	0.89	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	73.87	25.48	0.26	0.38	1.02
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	25.72	25.72	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	45.48	33.96	1.77	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	49.69	19.36	0.57	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	29.12	33.51	0.81	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.84	26.18	0.91	0.61	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	16.67	13.13	0.76	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	0.00	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	50.07	20.03	0.48	1.43	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	27.28	24.48	0.88	0.00	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	30.78	25.40	0.22	1.29	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	52.37	29.81	1.05	0.52	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.96	20.11	0.46	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	42.04	14.01	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	37.06	26.60	0.90	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	30.73	27.31	0.68	0.34	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	15.55	15.23	0.31	0.08	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	27.37	19.63	0.50	0.00	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	32.31	11.61	0.00	0.23	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	36.83	24.76	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	87.96	60.67	1.59	0.79	0.53
Smooth Muscle Cells - Prostate, donor1	11257-116F6	34.09	37.02	0.53	0.00	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	32.81	22.16	1.00	0.38	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	17.50	17.76	1.01	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	37.24	28.50	0.75	0.30	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	31.51	14.25	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	262.32	127.93	0.00	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.97	13.02	0.93	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	43.42	11.61	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	36.67	11.91	0.63	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	18.88	21.53	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	55.15	54.98	2.33	0.17	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	25.69	17.28	1.40	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	33.25	16.55	0.29	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	61.19	26.52	0.25	0.25	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	52.46	29.71	0.00	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	37.03	36.61	1.12	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	35.86	20.86	1.42	0.17	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	9.52	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	36.70	13.46	0.24	0.49	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	48.83	25.85	0.22	0.22	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.23	23.99	0.59	0.29	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.08	7.39	0.39	0.00	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	34.38	12.43	0.53	0.26	2.38
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	10.41	8.93	0.00	0.37	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	20.12	21.92	0.72	0.00	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	29.53	17.03	0.57	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	53.96	48.05	1.18	0.79	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	13.97	9.90	0.51	0.51	2.03
Smooth muscle cells - airway, control, donor2	11967-126D5	10.78	13.98	0.40	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	15.88	11.29	0.42	0.00	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	17.42	15.13	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	106.21	38.55	0.50	0.84	0.50
Synoviocyte, donor2	11368-117I9	56.99	15.92	0.34	0.67	0.17
Synoviocyte, donor3	11440-118H9	37.98	16.76	0.45	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	51.46	51.81	0.36	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	1.98	9.91	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	23.15	22.92	0.46	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	17.06	22.58	0.79	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	24.74	15.85	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	37.22	22.33	0.00	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	37.89	22.51	1.85	0.25	0.74
Urethra, donor2	10319-105A4	77.33	35.97	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	23.64	19.13	0.53	0.00	0.00
Urothelial Cells, donor2	11600-120H7	22.83	16.82	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	16.50	14.67	0.23	0.46	0.00
Urothelial cells, donor0	11216-116B1	24.52	20.73	0.67	0.22	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	84.53	47.16	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	91.50	48.61	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.08	22.59	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	43.39	19.63	1.72	0.69	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	39.51	28.47	1.74	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	63.52	36.44	4.16	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	70.67	41.30	0.92	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	68.47	17.35	1.83	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	88.94	50.08	1.97	1.23	0.99
Wilms' tumor cell line:HFWT	10597-108E3	180.41	59.84	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	42.18	24.58	2.79	0.00	0.56
achilles tendon, donor2	10292-104G4	51.66	28.93	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	39.26	29.83	0.76	0.51	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	43.18	56.19	2.32	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	60.30	50.45	4.99	0.36	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	40.00	63.13	5.17	0.54	1.36
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	57.90	46.10	1.97	0.56	1.12
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	52.02	47.37	3.38	0.63	0.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	40.83	28.58	1.09	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	55.96	42.30	2.64	0.44	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	55.13	47.78	2.86	0.41	1.63
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	50.09	40.38	2.33	0.39	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	81.88	75.62	2.02	0.92	1.10
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	93.61	27.30	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	42.53	53.45	3.25	0.46	1.63
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	49.97	50.23	2.59	0.52	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	47.93	52.60	0.88	0.58	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	72.04	56.70	1.86	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	59.63	31.67	0.41	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	103.44	53.41	0.92	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	66.57	49.50	3.84	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	50.35	43.37	2.43	0.00	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	58.49	51.51	1.20	0.24	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	48.78	45.22	1.34	0.45	0.67
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	68.71	48.70	0.33	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	234.13	167.24	5.57	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	48.21	54.62	1.51	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	94.64	70.22	1.31	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	54.36	59.98	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	61.47	35.09	1.41	0.24	0.24
adipose tissue, adult, pool1	10010-101C1	56.00	33.82	2.48	0.31	0.78
adipose, donor1	10184-103D4	66.85	41.64	2.35	1.17	0.00
adipose, donor2	10185-103D5	29.20	24.33	0.41	0.81	0.41
adipose, donor3	10186-103D6	56.64	27.50	0.27	0.27	1.63
adipose, donor4	10187-103D7	82.34	47.67	2.60	1.73	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	40.24	39.46	1.42	0.16	0.16
adrenal gland, adult, pool1	10081-102A9	43.65	36.38	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	31.48	23.21	1.33	0.13	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	37.52	19.65	0.00	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	40.34	10.67	0.70	0.46	0.23
amniotic membrane cells, donor2	12236-129G4	32.80	27.72	1.69	1.35	0.00
amniotic membrane cells, donor3	12237-129G5	36.53	15.91	0.00	0.29	0.29
amygdala - adult, donor10196	10167-103B5	945.08	442.30	2.37	4.74	7.11
amygdala, adult, donor10252	10151-102I7	666.09	223.25	2.23	8.11	1.82
amygdala, newborn, donor10223	10360-105E9	275.97	175.91	2.90	2.26	1.94
anaplastic carcinoma cell line:8305C	10428-106D5	19.35	10.06	0.51	0.25	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	57.36	50.30	1.99	0.22	0.66
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	91.53	18.71	1.34	0.00	0.00
aorta, adult, pool1	10052-101G7	168.28	44.33	2.16	0.59	0.98
appendix, adult	10189-103D9	57.83	40.36	1.16	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	47.46	26.48	1.38	0.00	0.00
artery, adult	10190-103E1	61.14	33.97	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	41.14	26.08	0.72	0.14	0.29
b cell line:RPMI1788	10427-106D4	18.59	25.58	2.08	0.15	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	130.12	42.45	0.55	1.66	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	46.04	25.20	1.19	0.10	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	24.10	8.54	0.33	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	31.32	17.34	0.56	0.56	0.56
bladder, adult, pool1	10011-101C2	80.39	36.29	1.74	0.76	1.09
blood, adult, pool1	10053-101G8	88.59	17.72	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	125.03	34.25	0.86	0.86	0.00
bone marrow, adult	10192-103E3	49.94	31.04	1.35	0.00	0.67
brain, adult, donor1	10084-102B3	518.68	240.89	2.05	13.33	8.20
brain, adult, pool1	10012-101C3	484.52	209.69	5.57	5.01	3.67
brain, fetal, pool1	10085-102B4	499.55	285.84	8.01	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	76.64	27.09	1.65	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	58.54	32.83	1.62	0.37	0.00
breast, adult, donor1	10080-102A8	102.91	44.83	3.79	0.00	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	20.71	31.76	0.76	0.13	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	31.85	27.52	1.86	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	18.19	17.96	1.84	0.23	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	36.31	17.67	1.45	0.73	0.24
carcinoid cell line:NCI-H1770	10703-109H1	29.15	31.03	0.00	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	58.19	23.41	0.88	0.44	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	54.51	42.46	2.22	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	60.42	27.15	0.53	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	164.64	87.50	4.61	6.91	0.00
caudate nucleus, adult, donor10252	10164-103B2	181.88	92.36	5.35	2.34	1.34
caudate nucleus, adult, donor10258	10379-105H1	174.22	142.13	6.11	3.82	0.00
caudate nucleus, newborn, donor10223	10354-105E3	72.15	50.91	2.56	0.00	1.83
cerebellum - adult, donor10196	10173-103C2	466.12	110.70	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	229.31	54.02	1.71	2.56	1.28
cerebellum, adult, pool1	10083-102B2	274.23	71.75	1.72	0.00	2.07
cerebellum, newborn, donor10223	10357-105E6	178.51	58.12	0.00	1.66	4.15
cerebral meninges, adult	10188-103D8	625.05	334.34	5.55	3.03	2.02
cerebrospinal fluid, donor2	10294-104G6	70.90	28.50	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	9.92	8.91	0.00	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	36.95	11.27	0.33	0.17	0.00
cervix, adult, pool1	10013-101C4	42.31	30.34	1.57	0.73	0.00
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	18.81	8.50	0.28	0.14	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	77.07	41.80	3.92	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	30.82	25.60	2.98	0.50	0.25
choriocarcinoma cell line:SCH	10785-110H2	79.84	40.04	1.23	0.49	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	309.52	107.68	2.13	1.42	0.71
chorionic membrane cells, donor1	12238-129G6	26.21	7.98	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	48.52	28.04	1.99	0.10	0.30
chorionic membrane cells, donor3	12240-129G8	34.62	23.08	0.55	0.00	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	40.39	30.29	4.04	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	48.22	33.62	1.15	0.77	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	38.65	27.67	0.21	0.84	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	86.80	40.32	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	100.14	38.94	1.69	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	73.91	32.78	0.20	0.00	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	35.63	38.87	0.59	0.29	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	44.57	39.35	1.56	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	92.12	63.77	6.40	4.57	3.43
clear cell carcinoma cell line:TEN	10636-108I6	26.37	10.24	1.04	0.69	0.35
colon carcinoma cell line:CACO-2	10513-107D9	30.75	31.48	1.28	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	31.93	22.42	3.42	0.38	0.00
colon, adult, donor1	10082-102B1	116.62	32.13	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	45.36	31.49	0.71	0.47	0.24
colon, fetal, donor1	10070-101I7	75.39	25.34	1.24	1.24	0.62
common myeloid progenitor CMP, donor1	12130-128D6	119.17	87.09	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	19.12	11.47	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	23.70	19.77	0.75	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	27.92	23.13	1.27	0.00	0.56
corpus callosum, adult, pool1	10042-101F6	99.73	47.21	1.44	0.44	0.33
cruciate ligament, donor2	10295-104G7	99.69	46.20	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	55.38	28.89	0.80	0.00	0.80
diencephalon, adult	10193-103E4	242.39	104.63	1.44	2.16	1.92
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	39.49	29.16	1.61	1.15	1.38
ductal cell carcinoma cell line:KLM-1	10438-106E6	33.34	37.70	1.28	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	28.65	24.31	0.96	0.24	0.00
ductus deferens, adult	10196-103E7	28.90	21.93	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	77.77	40.33	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	69.15	29.43	0.74	3.68	1.47
dura mater, adult, donor1	10041-101F5	72.84	32.87	1.24	0.33	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	46.86	13.77	0.89	0.44	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	44.71	45.14	0.43	0.43	0.72
embryonic pancreas cell line:1B2C6	10604-108F1	83.24	64.13	4.32	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	42.68	20.58	0.91	0.30	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	61.13	37.36	0.93	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	86.69	39.40	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	28.16	31.17	1.01	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	42.95	22.47	2.17	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	56.28	19.78	0.64	0.64	1.77
epidermoid carcinoma cell line:A431	10426-106D3	46.02	24.45	1.45	0.00	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	48.94	28.71	1.65	0.22	0.00
epididymis, adult	10197-103E8	53.37	39.98	1.47	0.63	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	26.97	23.60	0.53	0.18	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.65	6.69	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	27.91	13.63	1.31	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	28.05	15.35	0.79	0.10	0.20
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	29.80	19.49	0.78	0.45	0.45
esophagus, adult, pool1	10015-101C6	54.47	30.58	1.06	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	56.48	41.83	1.75	0.13	0.13
eye - muscle inferior rectus, donor1	10272-104E2	60.36	26.56	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	52.61	16.83	2.10	0.00	0.00
eye - muscle medial, donor2	10299-104H2	63.99	41.67	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	40.13	24.08	0.00	0.00	1.15
eye - vitreous humor, donor1	10268-104D7	145.74	64.13	0.00	1.46	0.00
eye, fetal, donor1	10054-101G9	117.46	35.59	0.25	0.76	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	29.36	27.18	0.90	0.51	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.99	34.66	0.95	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	491.83	316.56	5.63	2.25	1.03
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	34.83	28.52	1.20	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	9.33	8.69	0.37	0.00	0.09
gall bladder, adult	10198-103E9	58.19	34.04	0.97	0.24	0.48
gamma delta positive T cells, donor1	11937-126A2	18.25	16.11	2.68	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	26.89	14.94	2.99	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	23.87	10.35	0.63	0.21	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	23.40	11.99	0.58	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	37.55	34.92	0.00	0.49	0.16
gastric cancer cell line:GSS	10560-108A2	51.25	38.44	8.24	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	53.69	21.47	0.91	0.23	1.37
giant cell carcinoma cell line:LU65	10487-107B1	69.53	40.39	1.61	0.46	0.92
giant cell carcinoma cell line:Lu99B	10433-106E1	16.24	15.26	0.28	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	44.15	18.96	0.75	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	23.96	16.78	0.95	0.32	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	28.51	15.17	1.12	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	34.11	33.55	1.55	0.11	0.44
glioma cell line:GI-1	10413-106B8	28.41	8.79	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	155.26	73.62	3.64	2.92	0.00
globus pallidus, adult, donor10252	10161-103A8	110.33	38.57	0.98	0.98	0.00
globus pallidus, adult, donor10258	10367-105F7	98.58	65.72	0.00	2.74	2.74
globus pallidus, newborn, donor10223	10364-105F4	59.69	32.51	0.00	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	149.28	132.15	9.79	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	43.71	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	36.59	20.91	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	93.12	33.60	0.32	0.96	0.96
hIPS +CCl2, biol_rep1	14383-156B9	83.10	76.67	2.30	1.84	0.46
hIPS +CCl2, biol_rep2	14384-156C1	82.76	78.65	2.74	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	71.49	82.44	1.93	0.00	0.64
hIPS, biol_rep1	14380-156B6	84.80	64.68	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	82.30	77.50	0.00	0.69	0.69
hIPS, biol_rep3	14382-156B8	193.11	151.18	2.21	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	31.90	29.88	0.86	0.29	0.29
heart - mitral valve, adult	10205-103F7	80.42	32.29	1.49	0.30	0.90
heart - pulmonic valve, adult	10206-103F8	66.41	20.92	0.52	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	93.26	55.79	2.50	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	56.73	20.61	1.63	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	67.28	34.07	2.13	1.28	0.85
heart, adult, pool1	10016-101C7	62.09	37.03	3.91	0.00	0.23
heart, fetal, pool1	10046-101G1	53.39	29.67	1.54	0.62	0.31
hepatic mesenchymal tumor cell line:LI90	10778-110G4	48.13	20.36	0.31	0.31	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	83.24	35.68	2.38	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	44.64	25.97	0.77	0.44	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	40.66	27.55	1.70	0.61	0.73
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	39.81	25.57	0.61	0.20	0.20
hepatoma cell line:Li-7	10484-107A7	19.24	11.23	0.22	0.33	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	47.44	45.43	2.41	0.10	0.30
hippocampus - adult, donor10196	10169-103B7	823.30	366.23	4.73	5.68	3.79
hippocampus, adult, donor10252	10153-102I9	377.38	119.60	2.04	8.16	1.63
hippocampus, adult, donor10258	10374-105G5	628.41	341.59	1.00	6.97	1.99
hippocampus, newborn, donor10223	10363-105F3	284.80	193.86	1.41	2.47	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	93.99	84.23	6.71	4.88	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	73.83	71.28	4.91	1.18	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	64.74	77.69	4.82	1.52	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	34.96	37.22	1.69	0.56	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	46.22	34.34	3.61	3.10	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	42.90	46.69	1.90	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.08	23.06	1.75	0.58	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	47.18	27.79	0.86	0.86	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	33.37	26.28	0.42	0.00	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	58.72	31.49	2.13	0.47	0.47
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	54.97	30.86	1.29	0.64	1.93
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	52.52	26.26	3.37	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	73.39	69.64	5.79	0.47	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	91.87	69.76	1.47	4.42	7.86
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	63.71	70.69	4.36	1.75	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	38.37	30.55	1.72	0.76	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	47.97	31.40	2.18	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	29.49	22.49	1.50	2.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	28.45	24.49	1.70	0.94	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.38	25.92	0.91	1.82	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	27.88	17.85	1.57	0.31	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	48.01	16.17	0.33	0.82	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.90	13.06	0.29	0.58	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	31.69	14.95	1.49	1.49	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	93.11	72.42	4.06	2.96	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	90.72	77.03	1.43	0.00	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	93.91	81.66	5.31	3.67	1.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	66.90	36.97	1.06	2.46	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	49.73	38.64	1.58	0.32	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	40.55	35.71	0.91	0.30	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	39.30	26.37	2.07	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	45.83	21.25	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	26.94	25.14	0.77	1.28	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	58.29	23.01	0.51	0.77	2.81
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	70.42	37.10	1.51	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	38.65	22.18	0.00	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	102.40	72.93	3.14	1.21	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	61.95	70.41	3.12	2.67	2.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	71.22	76.59	2.93	0.49	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	60.51	42.18	1.53	0.92	0.61
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	211.46	84.58	13.01	9.76	26.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	49.31	43.68	0.99	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.97	35.57	0.55	0.55	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.83	27.50	0.72	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	27.40	26.33	1.42	0.00	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	45.35	22.67	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	65.55	29.39	1.76	0.27	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	47.68	30.71	1.08	0.81	1.08
immature langerhans cells, donor1	11904-125F5	214.54	51.82	1.45	1.45	1.70
immature langerhans cells, donor2	11905-125F6	106.94	43.57	2.38	0.79	0.00
insula, adult, pool1	10039-101F3	605.94	391.78	6.53	3.12	2.08
keratoacanthoma cell line:HKA-1	10791-110H8	25.69	15.61	0.33	0.00	0.00
kidney, adult, pool1	10017-101C8	43.36	33.14	1.20	0.20	0.30
kidney, fetal, pool1	10045-101F9	36.78	25.18	1.70	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	10.79	18.04	0.28	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	40.92	11.61	0.69	0.83	0.83
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	82.76	34.68	2.39	0.73	0.37
left atrium, adult, donor1	10079-102A7	45.77	25.61	0.54	0.00	0.00
left ventricle, adult, donor1	10078-102A6	92.53	41.97	1.52	1.01	0.51
leiomyoblastoma cell line:G-402	10721-110A1	92.75	58.28	2.46	0.55	0.00
leiomyoma cell line:10964C	10569-108B2	18.68	11.50	0.00	0.00	1.08
leiomyoma cell line:15242A	10570-108B3	32.61	14.67	0.54	1.09	0.00
leiomyoma cell line:15425	10571-108B4	35.45	19.91	0.73	1.21	1.46
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	31.75	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	63.78	11.50	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	44.74	25.50	0.71	0.00	0.47
liposarcoma cell line:KMLS-1	10782-110G8	26.71	11.72	0.31	0.16	0.47
liposarcoma cell line:SW 872	10726-110A6	53.24	30.95	1.83	0.12	0.24
liver, adult, pool1	10018-101C9	34.36	23.01	0.16	0.49	0.16
liver, fetal, pool1	10086-102B5	83.72	30.10	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	330.00	167.26	2.19	2.33	0.29
locus coeruleus, adult, donor10252	10165-103B3	209.10	78.06	2.03	1.66	1.29
locus coeruleus, adult, donor10258	10375-105G6	216.68	99.31	1.97	9.03	9.31
locus coeruleus, newborn, donor10223	10362-105F2	133.34	45.01	0.42	2.10	1.68
lung adenocarcinoma cell line:A549	10499-107C4	21.17	16.05	0.55	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	42.05	35.85	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	34.40	15.16	0.66	0.26	0.13
lung, adult, pool1	10019-101D1	78.91	44.89	2.60	0.35	0.47
lung, fetal, donor1	10068-101I5	51.94	38.53	0.86	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	106.31	52.69	0.46	0.00	0.46
lymph node, adult, donor1	10077-102A5	41.18	25.09	1.42	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	31.34	20.38	0.44	0.00	0.44
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	30.03	20.38	1.06	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	118.08	36.53	0.85	0.00	0.00
mature adipocyte, donor1	12231-129F8	52.83	11.54	1.33	0.00	0.00
mature adipocyte, donor2	12232-129F9	61.84	24.28	1.04	0.62	0.83
mature adipocyte, donor3	12233-129G1	33.90	12.56	0.47	0.00	0.00
mature adipocyte, donor4	12234-129G2	31.06	16.85	0.53	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	14.30	8.34	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	874.22	386.91	2.26	7.90	7.90
medial frontal gyrus, adult, donor10252	10150-102I6	592.73	179.12	4.60	6.62	2.02
medial frontal gyrus, adult, donor10258	10368-105F8	559.45	294.18	2.86	3.49	4.13
medial frontal gyrus, newborn, donor10223	10352-105E1	408.58	209.41	4.26	6.82	5.97
medial temporal gyrus - adult, donor10196	10183-103D3	899.44	317.93	4.89	26.49	22.28
medial temporal gyrus, adult, donor10252	10156-103A3	554.97	152.17	2.76	8.70	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	724.27	235.00	0.00	11.56	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	1851.62	588.50	14.35	129.18	129.18
medial temporal gyrus, newborn, donor10223	10353-105E2	349.60	232.59	5.74	0.72	1.79
medulla oblongata - adult, donor10196	10174-103C3	168.09	71.39	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	145.21	51.70	1.70	1.08	0.93
medulla oblongata, adult, pool1	10038-101F2	180.97	117.46	1.63	0.90	0.41
medulla oblongata, newborn, donor10223	10361-105F1	93.74	55.90	0.69	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	108.93	64.43	1.33	0.89	1.33
medulloblastoma cell line:ONS-76	10759-110E3	40.23	30.32	1.22	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	8.05	2.01	0.14	0.00	0.00
melanoma cell line:G-361	10465-106H6	21.72	15.20	0.27	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	33.83	11.94	0.36	0.18	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	104.86	63.44	1.76	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	86.32	67.66	2.85	1.04	2.33
mesenchymal precursor cell - adipose, donor1	11747-123G1	36.67	24.40	0.61	0.15	0.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	20.36	10.73	0.18	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	21.53	22.78	0.00	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	18.82	12.08	0.28	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	27.73	15.02	0.19	0.77	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	23.60	19.43	0.69	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.73	8.92	0.00	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	24.61	21.39	0.46	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	37.27	24.54	0.53	0.80	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	49.15	30.65	0.41	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	73.27	33.57	1.00	0.43	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.54	11.53	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	35.70	16.47	0.28	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	33.86	31.07	1.05	1.05	0.70
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	56.76	21.85	0.20	1.43	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	27.32	19.05	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	37.14	17.17	0.31	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	36.25	16.87	0.46	0.00	1.37
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	109.08	60.00	0.42	0.00	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	33.18	20.17	0.00	0.75	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	33.70	16.72	0.00	0.18	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	27.98	16.94	0.37	0.37	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	34.63	19.46	0.57	0.86	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	78.31	27.37	0.00	1.68	4.21
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	61.19	19.64	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	39.65	17.14	0.00	0.51	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	50.26	20.68	0.00	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	43.75	19.41	0.92	1.23	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.72	17.42	0.24	0.94	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	46.03	14.22	0.68	1.69	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	45.58	21.22	1.18	0.39	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	38.46	21.78	0.00	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	51.92	19.90	0.00	0.87	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	46.18	21.19	0.22	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	45.91	18.99	0.00	0.96	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	75.53	26.40	0.00	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	37.93	18.46	0.34	0.67	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	42.98	23.74	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.68	21.05	0.86	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	41.02	21.88	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	51.65	20.66	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	44.50	25.66	0.00	0.65	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	49.47	16.00	0.00	0.00	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	34.12	20.79	0.53	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	28.62	17.99	0.00	1.64	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	38.48	20.21	0.00	0.39	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	44.07	18.89	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	26.82	14.90	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	9.53	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	26.68	14.82	0.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	30.46	14.62	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	39.27	20.90	0.63	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.38	8.97	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	19.34	6.45	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	3.99	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	3.44	3.44	0.00	0.00	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	11.82	4.07	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	13.51	3.18	0.00	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	12.38	2.95	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	7.79	7.17	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	12.03	4.01	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	15.37	4.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	12.39	4.13	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	16.82	5.94	0.00	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	2.24	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	8.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	17.33	8.46	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	30.53	10.90	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	17.74	8.87	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	15.78	6.68	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	9.04	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	14.00	1.65	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.94	6.94	0.40	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.95	8.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	10.19	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	133.08	32.50	2.32	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	83.63	57.88	2.13	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	16.22	14.60	0.93	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	47.01	25.64	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	32.78	13.25	0.31	1.95	0.10
mesothelioma cell line:Mero-25	10850-111F4	51.52	26.10	1.13	0.23	1.36
mesothelioma cell line:Mero-41	10851-111F5	35.69	23.71	1.22	0.00	0.73
mesothelioma cell line:Mero-48a	10852-111F6	33.44	16.39	0.89	0.00	1.11
mesothelioma cell line:Mero-82	10853-111F7	36.79	25.75	0.79	0.26	0.53
mesothelioma cell line:Mero-83	10854-111F8	31.83	20.09	0.51	0.34	0.51
mesothelioma cell line:Mero-84	10855-111F9	48.79	18.20	0.76	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	11.39	10.15	0.21	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	67.42	47.71	1.16	0.50	0.50
mesothelioma cell line:NCI-H226	10846-111E9	34.75	17.19	0.18	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	29.04	24.09	1.20	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	54.71	38.93	1.78	1.02	2.80
mesothelioma cell line:No36	10857-111G2	32.29	23.49	0.33	0.65	0.98
mesothelioma cell line:ONE58	10858-111G3	27.10	14.63	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	48.36	23.03	0.77	0.19	0.38
migratory langerhans cells, donor2	11902-125F3	32.60	16.49	0.61	0.37	0.24
migratory langerhans cells, donor3	11903-125F4	34.46	31.59	2.15	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	23.51	9.14	0.98	2.61	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	42.60	23.74	0.85	0.21	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	108.04	38.47	0.69	0.46	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	33.11	23.98	0.57	0.57	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	63.75	31.23	1.85	0.18	0.18
myeloma cell line:PCM6	10474-106I6	6.72	5.14	0.40	0.40	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	138.49	41.09	2.03	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	37.46	12.95	0.00	0.20	0.78
nasal epithelial cells, donor1, tech_rep1	12226-129F3	30.75	16.38	0.22	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.00	15.30	0.44	0.15	0.15
nasal epithelial cells, donor2	12227-129F4	40.30	17.66	0.00	0.00	1.10
neuroblastoma cell line:CHP-134	10508-107D4	47.62	41.64	1.15	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	82.32	67.35	2.81	0.19	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	18.77	7.38	0.42	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	74.91	32.61	0.37	0.37	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	41.28	21.11	1.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.36	23.76	1.43	0.32	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	32.60	45.48	2.21	0.40	0.40
neuroepithelioma cell line:SK-N-MC	10728-110A8	71.21	80.11	7.63	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	103.01	46.58	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	475.99	312.37	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	39.84	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	85.24	66.29	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	34.33	38.05	4.06	0.51	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	71.25	24.02	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	28.21	22.44	0.00	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	42.83	20.50	0.53	0.79	0.79
nucleus accumbens, adult, pool1	10037-101F1	336.34	247.94	6.19	1.41	1.03
occipital cortex - adult, donor10196	10172-103C1	632.54	263.73	4.12	10.30	4.12
occipital cortex, adult, donor10252	10163-103B1	334.38	82.39	1.61	5.37	1.34
occipital cortex, newborn, donor10223	10355-105E4	317.36	257.31	2.91	1.46	3.64
occipital lobe, adult, donor1	10076-102A4	550.25	292.31	6.30	12.60	5.77
occipital lobe, fetal, donor1	10073-102A1	338.99	135.60	6.44	3.86	2.57
occipital pole, adult, pool1	10036-101E9	383.25	248.11	4.42	1.26	1.34
olfactory region, adult	10195-103E6	787.33	275.69	2.29	5.92	4.01
optic nerve, donor1	10277-104E7	72.04	26.01	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	22.10	6.83	0.34	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	15.39	17.45	0.55	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	32.51	14.56	0.34	1.19	0.51
oral squamous cell carcinoma cell line:SAS	10544-107H4	29.34	21.95	0.46	0.23	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	118.17	37.92	1.18	0.59	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	84.09	62.60	1.87	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	21.63	8.48	0.00	0.21	0.21
ovary, adult, pool1	10020-101D2	57.13	31.97	2.27	0.26	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	55.00	32.81	0.92	0.55	0.18
pancreas, adult, donor1	10049-101G4	47.97	31.98	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	104.83	38.02	0.28	0.84	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	38.16	13.63	0.51	0.34	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	49.51	24.18	0.50	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	437.84	311.17	3.94	2.11	1.56
parietal cortex, adult, donor10258	10373-105G4	303.14	177.63	5.14	1.47	0.73
parietal lobe - adult, donor10196	10171-103B9	573.69	256.75	1.88	2.82	5.64
parietal lobe, adult, donor10252	10157-103A4	412.45	157.06	0.86	3.99	1.43
parietal lobe, adult, pool1	10034-101E7	424.30	289.30	4.23	2.29	1.23
parietal lobe, fetal, donor1	10072-101I9	294.83	179.42	3.88	4.85	3.88
parietal lobe, newborn, donor10223	10356-105E5	320.02	217.96	4.49	4.11	2.62
parotid gland, adult	10199-103F1	39.47	15.42	2.47	0.00	0.00
penis, adult	10200-103F2	51.03	33.30	1.07	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.87	23.80	1.86	0.19	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	33.66	34.24	1.31	0.44	0.00
pineal gland - adult, donor10196	10179-103C8	121.27	33.54	2.58	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	53.89	21.91	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	40.76	20.07	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	67.79	27.32	4.05	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	76.09	29.71	0.52	2.08	0.00
pituitary gland, adult, donor10258	10378-105G9	65.55	26.39	3.40	0.00	0.00
placenta, adult, pool1	10021-101D3	40.42	23.87	1.51	0.32	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	45.95	29.93	1.72	0.53	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	25.37	13.70	0.47	0.31	0.16
pons, adult, pool1	10033-101E6	291.42	248.13	4.99	1.64	0.69
postcentral gyrus, adult, pool1	10032-101E5	491.84	280.44	4.36	3.31	1.66
promyelocytes/myelocytes PMC, donor1	12132-128D8	435.01	209.14	4.18	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	55.08	33.05	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	41.51	33.21	3.06	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	43.38	35.21	0.73	0.36	0.54
prostate, adult, pool1	10022-101D4	42.53	27.39	1.09	0.00	0.09
putamen, adult, donor10196	10176-103C5	215.76	129.60	6.61	2.36	1.89
putamen, adult, donor10252	10152-102I8	121.56	98.04	9.80	1.96	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	89.61	77.59	1.09	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	99.79	95.68	3.87	1.21	0.97
putamen, newborn, donor10223	10365-105F5	66.72	35.98	0.75	0.00	3.00
rectal cancer cell line:TT1TKB	10469-106I1	47.13	27.06	1.16	0.00	0.29
rectum, fetal, donor1	10067-101I4	219.78	83.46	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	31.16	21.20	0.64	0.85	0.85
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	10.36	9.53	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	64.11	28.53	0.89	0.10	0.10
retinoblastoma cell line:Y79	10475-106I7	39.49	35.33	1.04	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	45.98	41.56	1.72	0.49	0.25
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	42.18	58.49	1.97	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	47.74	31.83	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	12.79	15.05	0.49	0.00	0.00
salivary acinar cells, donor2	11772-123I8	21.75	15.56	0.28	0.14	0.14
salivary acinar cells, donor3	11773-123I9	43.70	35.09	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	42.90	26.31	1.72	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.31	12.39	0.25	0.00	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	14.46	9.76	0.59	0.12	0.00
seminal vesicle, adult	10201-103F3	23.28	20.10	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.90	12.88	1.21	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	25.16	14.34	0.50	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	37.13	44.16	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	78.04	32.24	1.07	0.40	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	49.74	17.24	0.33	0.44	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	26.84	17.81	0.26	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	27.66	20.57	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	37.90	21.71	1.92	0.24	0.12
skeletal muscle, fetal, donor1	10066-101I3	53.27	27.14	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	81.42	33.93	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	56.81	23.99	2.52	0.63	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	76.38	53.36	2.00	1.00	1.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	50.12	16.39	0.00	0.95	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	31.23	32.00	2.89	0.58	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	29.67	19.45	0.99	0.16	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	59.51	47.45	2.09	0.16	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	61.89	29.42	0.65	0.65	0.22
small intestine, adult, pool1	10024-101D6	54.11	31.17	0.48	0.60	0.36
small intestine, fetal, donor1	10064-101I1	65.11	31.45	0.98	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	61.55	18.46	0.00	2.56	1.03
smooth muscle, adult, pool1	10048-101G3	92.27	33.86	1.55	0.00	0.78
somatostatinoma cell line:QGP-1	10781-110G7	36.45	15.55	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	172.28	75.93	1.15	2.29	0.92
spinal cord, adult, donor10252	10159-103A6	108.03	35.09	1.58	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	105.84	40.82	0.69	0.69	2.77
spinal cord, fetal, donor1	10056-101H2	250.03	121.97	2.44	2.44	1.22
spinal cord, newborn, donor10223	10359-105E8	121.69	59.70	1.84	1.84	2.76
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	152.64	44.21	0.45	0.60	1.34
spleen, adult, pool1	10025-101D7	50.44	35.02	1.87	0.22	0.00
spleen, fetal, pool1	10044-101F8	56.73	42.27	2.38	0.24	0.40
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	16.25	16.56	1.04	0.21	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	25.06	15.38	0.76	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	27.96	15.38	0.70	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	50.43	15.25	0.00	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	33.66	22.29	0.90	0.11	0.34
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	32.62	22.87	1.69	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	69.38	29.19	0.85	0.42	1.27
stomach, fetal, donor1	10062-101H8	231.75	74.76	3.20	0.00	0.00
submaxillary gland, adult	10202-103F4	32.47	13.67	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27	0.00	0.00	54.27
substantia nigra, adult, donor10252	10158-103A5	85.37	20.98	1.04	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	270.00	153.11	1.03	1.55	1.55
substantia nigra, newborn, donor10223	10358-105E7	79.14	36.74	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	32.10	30.49	1.15	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	617.81	348.41	6.02	3.31	2.20
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	334.05	195.16	6.41	5.70	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	219.77	144.61	3.52	4.40	3.08
tenocyte, donor1	11763-123H8	63.54	22.34	1.05	0.35	1.75
tenocyte, donor2	11765-123I1	49.60	14.50	0.00	1.53	1.14
tenocyte, donor3	11768-123I4	66.72	35.58	2.22	1.85	1.48
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	51.84	58.13	3.57	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	47.02	31.75	1.70	0.15	0.62
teratocarcinoma cell line:PA-1	10807-111A6	59.82	82.29	2.79	0.93	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	45.70	49.89	2.03	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	18.91	30.25	3.03	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	47.11	32.94	0.87	0.44	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	18.57	39.08	2.93	1.30	1.30
testis, adult, pool1	10026-101D8	30.39	21.05	1.72	0.97	0.43
testis, adult, pool2	10096-102C6	24.81	18.95	0.45	1.80	0.45
thalamus - adult, donor10196	10168-103B6	274.89	96.05	1.10	0.00	2.21
thalamus, adult, donor10252	10154-103A1	94.08	32.04	1.56	1.09	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	301.77	135.49	0.00	0.00	1.54
thalamus, adult, donor10258, tech_rep2	10370-105G1	139.49	81.36	1.32	2.14	3.46
thalamus, newborn, donor10223	10366-105F6	283.63	126.57	0.58	1.73	2.88
throat, adult	10209-103G2	39.20	21.97	0.75	0.50	1.00
throat, fetal, donor1	10061-101H7	101.47	29.56	1.22	1.22	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	46.30	32.00	0.40	0.20	0.00
thymus, adult, pool1	10027-101D9	33.70	29.82	3.28	0.80	0.40
thymus, fetal, pool1	10043-101F7	37.30	27.43	2.49	0.42	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	83.23	34.57	1.06	0.80	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	35.62	23.89	0.98	0.14	0.28
thyroid, adult, pool1	10028-101E1	39.38	22.58	1.40	0.09	0.28
thyroid, fetal, donor1	10060-101H6	76.73	29.79	0.79	0.53	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	70.83	49.27	6.16	0.00	0.00
tongue, adult	10203-103F5	32.33	20.93	0.47	1.40	1.16
tongue, fetal, donor1	10059-101H5	80.39	32.71	1.18	0.39	1.18
tonsil, adult, pool1	10047-101G2	35.96	30.75	1.40	0.10	0.00
trachea, adult, pool1	10029-101E2	55.79	30.35	0.90	0.16	0.25
trachea, fetal, donor1	10058-101H4	63.47	20.77	1.15	0.38	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	57.75	41.45	1.42	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	42.25	26.95	1.22	0.20	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	35.41	42.93	3.76	1.10	0.47
tridermal teratoma cell line:HGRT	10694-109G1	148.40	68.49	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	28.02	18.37	0.42	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	58.42	10.43	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	46.75	36.34	0.34	0.00	0.51
uterus, fetal, donor1	10055-101H1	78.33	37.88	2.05	1.02	0.00
vagina, adult	10204-103F6	63.33	31.02	2.58	1.29	0.00
vein, adult	10191-103E2	55.46	33.76	1.32	0.66	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	22.43	17.62	0.80	0.27	0.27